Related Experiment Videos
The CD34 antigen: structure, biology, and potential clinical applications
1University of Toronto Autologous Bone Marrow Transplant Program, Toronto Hospital, Ontario, Canada.
Journal of Hematotherapy
|January 1, 1992
Summary
The CD34 antigen is a key molecule on primitive hematopoietic progenitor cells. CD34 antibodies are crucial for isolating these cells for research and clinical applications like bone marrow transplantation.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Mature blood cells exhibit diverse functions, reflected in their cell-surface molecules.
- Monoclonal antibodies identify cell-surface molecules on hematopoietic cells.
- CD34 antigen is uniquely expressed on primitive bone marrow progenitor cells.
Purpose of the Study:
- To review the biology of the CD34 molecule.
- To assess the roles of CD34 antibodies in immunopathology.
- To evaluate CD34 antibodies in progenitor/stem cell purification for clinical applications.
Main Methods:
- Utilizing monoclonal antibodies for cell-surface molecule identification.
- Employing CD34 antibodies for positive selection of hematopoietic stem/progenitor cells.
- Reviewing existing literature on CD34 biology and applications.
Main Results:
- CD34 expression is restricted to primitive progenitor cells, suggesting a role in early hematopoiesis.
- CD34 antibodies facilitate enrichment of progenitor cells for in vitro studies.
- CD34 antibody-based positive selection offers an alternative to negative selection for bone marrow manipulation.
Conclusions:
- The CD34 molecule plays a significant role in early hematopoiesis.
- CD34 antibodies are vital tools for progenitor cell purification in research and clinical settings.
- Pure progenitor cell populations may enable genetic therapies for blood disorders.